Fz7-21

Fz7-21 is a synthetic peptide designed as a selective agonist for the Frizzled-7 (FZD7) receptor, a key member of the Frizzled family of G protein-coupled receptors involved in Wnt signaling pathways. As a specialized tool compound, Fz7-21 enables precise modulation of FZD7-mediated signaling, providing researchers with an invaluable resource for dissecting the molecular mechanisms underlying Wnt pathway activity. Its sequence specificity and receptor selectivity make it particularly relevant for studies focused on cellular communication, developmental biology, and the intricate regulation of signal transduction processes governed by the Wnt/FZD7 axis.

Signal transduction research: Fz7-21 serves as a robust tool for investigating the dynamics of Wnt/FZD7 signaling in cellular models. By selectively activating FZD7, it allows researchers to probe downstream effects such as β-catenin stabilization, gene transcription changes, and pathway-specific cellular responses. This targeted approach facilitates the elucidation of receptor-specific contributions within the broader Wnt signaling network, advancing the understanding of how individual Frizzled receptors modulate cellular fate decisions and intercellular communication.

Developmental biology studies: The compound's ability to mimic endogenous Wnt ligands and stimulate FZD7 provides unique opportunities to study developmental processes regulated by Wnt signaling. In embryogenesis and tissue patterning models, Fz7-21 can be employed to delineate the role of FZD7 in cell differentiation, tissue morphogenesis, and organogenesis. Its use supports the generation of mechanistic insights into how spatial and temporal activation of specific Wnt receptors influences developmental outcomes.

Cellular differentiation assays: Researchers utilize Fz7-21 to direct lineage specification in stem cell and progenitor cell cultures. By modulating FZD7 activity, it becomes possible to assess how receptor-selective Wnt pathway activation impacts the differentiation of pluripotent or multipotent cells into defined cell types. Such applications are critical for optimizing in vitro differentiation protocols and for unraveling the molecular cues that guide cell fate choices in regenerative biology contexts.

Pharmacological screening: The peptide's receptor specificity makes it a valuable reference agonist in high-throughput screening platforms aimed at identifying novel FZD7 modulators. Fz7-21 can be used as a positive control or benchmarking tool for evaluating the efficacy, potency, and selectivity of small molecules, biologics, or other peptides targeting the Wnt/FZD7 axis. This application supports drug discovery efforts focused on modulating Wnt signaling for research purposes and expands the toolkit available for chemical biology studies.

Peptide structure-activity relationship analysis: Fz7-21 provides a foundation for structure-activity relationship (SAR) investigations targeting the Frizzled receptor family. By serving as a template for analog synthesis and sequence modification, it enables systematic exploration of the molecular features required for receptor binding, activation, and signaling specificity. Such studies contribute to the rational design of next-generation peptide agonists or antagonists with tailored selectivity profiles, advancing both basic research and the development of novel research reagents.

1. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

5. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging